Basic Research Open Access
Copyright ©The Author(s) 2004. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Dec 1, 2004; 10(23): 3470-3474
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3470
Ethanol inhibits the motility of rabbit sphincter of Oddi in vitro
Réka Sári, Attila Pálvölgyi, Zoltán Rakonczay Jr, Tamás Takács, János Lonovics, László Czakó, Peter Hegyi, First Department of Medicine, Faculty of Medicine, University of Szeged H-6720, Koranyi fasor 10, Hungary
Zoltán Szilvássy, Department of Pharmacology, Medical University of Debrecen H-4032, Nagyerdei krt, 98, Hungary
Author contributions: All authors contributed equally to the work.
Supported by The Wellcome Trust (Grant No. 022618), and by the Hungarian Scientific Research Fund (D42188, T43066 and T042589)
Correspondence to: Péter Hegyi, M.D., Ph.D., First Department of Medicine, University of Szeged, H-6701, PO Box 469, Hungary. hep@in1st.szote.u-szeged.hu
Telephone: +36-62-545200 Fax: +36-62-545185
Received: April 10, 2004
Revised: May 12, 2004
Accepted: May 25, 2004
Published online: December 1, 2004

Abstract

AIM: The role of the sphincter of Oddi (SO) in ethanol (ETOH)-induced pancreatitis is controversial. Our aim was to characterise the effect of ETOH on basal and stimulated SO motility.

METHODS: SOs removed from white rabbits were placed in an organ bath (Krebs solution, pH7.4, 37 °C). The effects of 2 mL/L, 4 mL/L, 6 mL/L and 8 mL/L of ETOH on the contractile responses of the sphincter were determined. SOs were stimulated with either 0.1 μmol/L carbachol, 1 μmol/L erythromycin or 0.1 μmol/L cholecystokinin (CCK).

RESULTS: ETOH at a dose of 4 mL/L significantly decreased the baseline contractile amplitude from 11.98 ± 0.05 mN to 11.19 ± 0.07 mN. However, no significant changes in the contractile frequency were observed. ETOH (0.6%) significantly decreased both the baseline amplitude and the frequency compared to the control group (10.50 ± 0.01 mN, 12.13 ± 0.10 mN and 3.53 ± 0.13 c/min, 5.5 ± 0.13 cycles(c)/min, respectively). Moreover, 0.8% of ETOH resulted in complete relaxation of the SO. Carbachol (0.1 μmol/L) or erythromycin (1 μmol/L) stimulated the baseline amplitudes (by 82% and 75%, respectively) and the contractile frequencies (by 150% and 106%, respectively). In the carbachol or erythromycin-stimulated groups 2-6 mL/L of ETOH significantly inhibited both the amplitude and the frequency. Interestingly, a 4-5 min administration of 6 mL/L ETOH suddenly and completely relaxed the SO. CCK (0.1 μmol/L) stimulated the baseline amplitude from 12.37 ± 0.05 mN to 27.40 ± 1.82 mN within 1.60 ± 0.24 min. After this peak, the amplitude decreased to 17.17 ± 0.22 mN and remained constant during the experiment. The frequency peaked at 12.8 ± 0.2 c/min, after which the constant frequency was 9.43 ± 0.24 c/min throughout the rest of the experiment. ETOH at a dose of 4 mL/L significantly decreased the amplitude from 16.13 ± 0.23 mN to 14.93 ± 0.19 mN. However, no significant changes in the contractile frequency were observed. ETOH at a dose of 6 mL/L inhibited both the amplitudes and the frequencies in the CCK-stimulated group, while 8 mL/L of ETOH completely relaxed the SO.

CONCLUSION: ETOH strongly inhibits the basal, carbachol, erythromycin, and CCK-stimulated rabbit SO motility. Therefore, it is possible that during alcohol-intake the relaxed SO opens the way for pancreatic fluid to flow out into the duodenum in rabbits. This relaxation of the SO may protect the pancreas against alcohol-induced damage.




INTRODUCTION

It is well documented that ethanol (ETOH) can cause acute pancreatitis[1,2], but the mechanisms by which alcohol causes this severe pancreatic injury are not clear. Two main hypotheses have been put forward to explain the role of the sphincter of Oddi (SO) in ETOH induced pancreatitis. One is the obstruction-hypersecretion theory which holds that ETOH induces spasm of the SO and can increase the pressure in the pancreatic ductal system, which may lead to the disruption of small pancreatic ducts. Therefore, pancreatic juice can enter the parenchyma evoking acute pancreatitis[3,4]. The other is the duodenopancreatic reflux theory which believes that ETOH reduces the SO motility, thus, the reflux of bile, activated enzymes, or other substances into the pancreatic ducts may cause pancreatitis after alcohol ingestion[5,6]. Despite these contradictory theories, no data are available concerning the effect of alcohol on physiologically (postprandial)-stimulated SO motility.

Cholecystokinin (CCK) is generally regarded as the major hormone regulating postprandial SO motility. This regulatory effect of CCK is rather complex. CCK could directly stimulate SO motility in guinea pigs[7], opossum[8], rabbits[9-11] and dogs[12]. On the other hand, CCK could induce acetylcholine (Ach) and vasoactive intestinal peptide release from pre- and postjunctional sites in the enteric nervous system via CCKA and CCKB receptors in the canine gastrointestinal tract, which suggests an indirect effect of CCK[13]. Others have also demonstrated that the contractile response of the guinea pig SO to CCK consists of a direct effect and an indirect effect mediated by Ach release from postganglionic parasympathetic neurons[7,14].

Motilin is also a key peptide regulating phasic contractile activity of the stomach, duodenum, SO, and gallbladder[15]. This regulation is mediated by the migrating myoelectric complex of the gastrointestinal tract[16]. Motilin provoked an increase of the SO spike activity in a dose-dependent manner in rabbits[17]. Erythromycin, a motilin agonist, has been found to stimulate interdigestive motility of the duodenum and SO in dogs[18], Australian opossum[19] and also in humans[20]. However, there are no available data concerning the effect of erythromycin on rabbit SO motility.

The parasympathetic nervous system plays an important role in the stimulation of gastrointestinal motility after a meal. The parasympathetic neurotransmitter Ach and its analogues have been shown to stimulate SO motility in different species[21]. Furthermore, Ach can be released from postganglionic parasympathetic neurons after hormonal stimuli, as described above.

In this study our aim was to characterise the effects of ETOH on the basal and differently stimulated SO motility in rabbits.

MATERIALS AND METHODS
Ethics

The present experiments conformed to the European Guiding Principles for Care and Use of Experimental Animals. In addition, the experimental protocol applied was approved by the local ethical boards of the Universities of Szeged and Debrecen, Hungary.

Isometric tension measurements

Isometric tension measurements were described in detail previously[22]. Biliary SO muscle rings of approximately 6 mm long from adult male New Zealand white rabbits weighing 2-2.5 kg were prepared. The papilla Vateri was eliminated and the ampullary part of the muscle rings of approximately 3 mm long were mounted horizontally on two small L-shaped glass hooks, of which one was connected to a force transducer (SG-O2, Experimetria, Budapest, Hungary) attached to a six channel polygraph (R61 6CH, Mikromed, Budapest, Hungary) for measurement and recording of isometric tension as described[22]. One muscle ring was prepared from one animal. The experiments were carried out in an organ bath (5 mL) containing Krebs bicarbonate buffer (in mmol/L: NaCl 118.1, KCl 4.7, MgSO4 1.0, KH2PO4 1.0, CaCl2 2.5, NaHCO3 25.0, glucose 11.1) which was maintained at 37 °C and aerated continuously with carbogen (50 mL/L CO2/950 mL/L O2).

Experimental protocol

The muscle rings underwent brief experimental protocols as follows. Phasic activity of SO: contractile frequencies and their amplitudes were measured over 50 min in each experiment. The initial tension was set at 10 milliNewtons (mN) and the rings were allowed to equilibrate for over 30 min. After that amplitudes and frequencies were recorded for 60 min. In the first 10 min, baseline phasic activity was measured. From the second 10 min, phasic activities were stimulated with 0.1 μmol/L carbachol, 1 μmol/L erythromycin or 0.1 μmol/L CCK. During the last 40 min, ETOH was administered at the doses of 2 mL/L, 4 mL/L, 6 mL/L and 8 mL/L for equal periods (4 times, 10 min). The control SOs received no treatments.

Drugs and chemicals

All laboratory chemicals (including ions, carbachol, erythromycin, CCK and ETOH) were obtained from Sigma Chemical Company (Budapest, Hungary). CCK and carbachol were dissolved in Krebs solution, while erythromycin was dissolved in dimethyl sulfoxide.

Data and statistical analysis

Parameters producing the data for evaluation were as follows. The amplitude of contractions (mN) was referred to as the difference between peak contractions and relaxations. The average of the amplitudes was calculated every minute (results were expressed as mean ± SE, n = number of frequencies in a minute). The frequencies of contractions (c/min) were calculated every minute. Statistical analysis was performed for 10 min of each of the experiments using either Student’s t-test (when the data consisted of two groups) or ANOVA (when three or more data groups were compared). Results were expressed as mean ± SE, n = 5, P < 0.05 was considered statistically significant.

RESULTS
Effect of ETOH on basal SO motility

The amplitudes and frequencies of the basal SO motility were stable during the control experiments (11.98 ± 0.04 mN and 5.37 ± 0.07 c/min, respectively). ETOH (2 mL/L) had no effects on the baseline amplitudes and frequencies. When ETOH was administered at a dose of 4 mL/L, the baseline amplitude was significantly decreased vs the control (11.19 ± 0.07 mN and 11.98 ± 0.05 mN, respectively) (Figure 1A, B). However, no significant changes in the contractile frequency were observed vs the control (Figure 1C,D). ETOH (6 mL/L) significantly decreased both the baseline amplitude and frequency vs control (10.50 ± 0.01 mN, 12.13 ± 0.10 mN and 3.53 ± 0.13 c/min, 5.50 ± 0.17 c/min, respectively). ETOH (8 mL/L) completely relaxed the SO within 10 s. Therefore, neither the frequencies nor the amplitudes could be detected during the last 10 min of the experiments.

Figure 1
Figure 1 Basal SO motility inhibited by ETOH. Sphincter of Oddi (SO) was exposed to increasing doses of ethanol (ETOH; 2 mL/L, 4 mL/L, 6 mL/L and 8 mL/L). Each concentration of ETOH was administered for 10 min. A: Effect of ETOH on the baseline amplitude. Representative experiments of the control and the ETOH-treated groups are shown. B: Summary of the effect of ETOH on the baseline amplitude. Mean ± SE, n = 5, aP < 0.05 vs the control; o: no contractile activity. C: Effect of ETOH on the contractile frequency. Representative experiments of the control and the ETOH-treated groups are shown. D: Summary of the effect of ETOH on the contractile frequency. Mean ± SE, n = 5, aP < 0.05 vs the control; o: no contractile activity.
Effect of ETOH on carbachol-stimulated SO motility

Carbachol (0.1 μmol/L) stimulated the baseline amplitude by 82% and the contractile frequency by 150%. This carbachol-stimulated SO motility was stable during the experiment (Figure 2A-C). ETOH (2 mL/L) significantly inhibited both the amplitude and frequency vs the carbachol-stimulated group (19.42 ± 1.16 mN, 20.81 ± 0.49 mN and 12.32 ± 0.16 c/min, 12.91 ± 0.10 c/min, respectively) (Figure 2A-D). ETOH (4 mL/L) further reduced the amplitude (13.92 ± 0.49 mN) and the frequency (9.24 ± 0.21 c/min) of the SO motility. ETOH (6 mL/L) decreased the contractile frequency of the SO by 50% (4.61 ± 0.46 c/min). However, it did not modify the amplitude frequency (12.23 ± 0.22 mN). Interestingly, a 4.20 ± 1.47 min administration of 6 mL/L ETOH suddenly and completely relaxed the SO.

Figure 2
Figure 2 Effect of ETOH on carbachol, erythromycin, CCK stimulated SO motility. All of the SOs were stimulated by 0.1 μmol/L carbachol for 40 min. Different concentrations of ETOH were administered as described in Figure 1. A: Effect of ETOH on the carbachol-stimulated baseline amplitude. Representative experiments of the control (carbachol-treated) and the ETOH-carbachol-treated groups are shown. B: Summary of the effect of ETOH on the carbachol-stimulated baseline amplitude. Mean ± SE, n = 5, aP < 0.05 vs control, cP < 0.05 vs the carbachol-stimulated group, o: no contractile activity. C: Effect of ETOH on the contractile frequency. Representative experiments of the (carbachol-treated) and the ETOH-carbachol-treated groups are shown. D: Summary of the effect of ETOH on the carbachol-stimulated contractile frequency. Mean ± SE, n = 5, aP < 0.05 vs control, cP < 0.05 vs the carbachol-stimulated group, o: no contractile activity. E: Effect of ETOH on the erythromycin-stimulated baseline amplitude. Representative experiments of the control (erythromycin-treated) and the ETOH-erythromycin-treated groups are shown. F: Summary of the effect of ETOH on the erythromycin-stimulated baseline amplitude. Mean ± SE, n = 5, aP < 0.05 vs the control, cP < 0.05 vs the erythro-mycin-stimulated group, o: no contractile activity. G: Effect of ETOH on the contractile frequency. Representative experiments of the control (erythromycin-treated) and the ETOH-erythromycin-treated groups are shown. H: Summary of the effect of ETOH on the erythromycin-stimulated contractile frequency. Mean ± SE, n = 5, aP < 0.05 vs the control, cP < 0.05 vs the erythromycin-stimulated group, o: no contractile activity. I: Effect of ETOH on the carbachol-stimulated baseline amplitude. Representative experiments of the control (CCK-treated) and the ETOH-CCK-treated groups are shown. J: Summary of the effect of ETOH on the CCK-stimulated baseline amplitude. Mean ± SE, n = 5, aP < 0.05 vs the control; o: no contractile activity. In the 0.1 μmol/L CCK-treated group, the first column represents the peak amplitude of contractile frequencies. The second column represents the constant amplitudes after the peak. aP < 0.05 vs the constant amplitude of the CCK-treated group. K: Effect of ETOH on the contractile frequency. Representative experiments of the (CCK-treated) and ETOH-CCK-treated groups are shown. L: Summary of the effect of ETOH on the CCK-stimulated contractile frequency. Mean ± SE, n = 5, aP < 0.05 vs the control; o: no contractile activity. In the 0.1 μmol/L CCK-treated group, the first column represents the peak of frequencies. The second column represents the constant frequencies after the peak. cP < 0.05 vs the constant frequency of the CCK-treated group.
Effect of ETOH on erythromycin-stimulated SO motility

Erythromycin (1 μmol/L) stimulated the baseline amplitude by 75% and the contractile frequency by 106%. This erythromycin-stimulated SO motility was constant over the experiment. ETOH (2 mL/L) significantly inhibited both the amplitude and the frequency vs the carbachol-stimulated group (19.10 ± 0.25 mN, 19.65 ± 0.45 mN and 9.66 ± 0.29 c/min, 10.45 ± 0.20 c/min, respectively). ETOH (4 mL/L) significantly decreased both the amplitude (16.27 ± 0.33 mN) and the frequency (8.32 ± 0.22 c/min), (Figure 2E-H). Administration of 6 mL/L ETOH caused a further decrease in the amplitude and frequency (11.85 ± 0.41 mN and 4.10 ± 0.37 c/min, respectively). Similar to that seen in the carbachol-stimulated group, a 4.10 ± 0.55 min administration of 6 mL/L ETOH suddenly and completely relaxed the SO.

Effect of ETOH on CCK-stimulated SO motility

CCK (0.1 μmol/L) stimulated the baseline amplitude from 12.37 ± 0.05 mN to 27.4 ± 1.82 mN within 1.60 ± 0.24 min. After this peak, the amplitude decreased to 17.17 ± 0.22 mN and was constant during the experiment. The frequency peaked at 12.8 ± 0.2 c/min, after which the constant frequency was 9.43 ± 0.24 c/min thro ughout the rest of the experiment. ETOH (2 mL/L) mildly decreased the amplitude frequency (16.13 ± 0.23 mN and 17.05 ± 0.14 mN), but had no effect on the contractile frequency of the SO (9.32 ± 0.15 mN and 9.50 ± 0.31 mN). ETOH (4 mL/L) further decreased the amplitude frequency from 16.13 ± 0.23 mN to 14.93 ± 0.19 mN, but still had no effect on the contractile frequency of the SO (9.82 ± 0.23 c/min). ETOH (6 mL/L) further decreased the amplitude and frequency of the SO to 12.13 ± 0.11 mN and 7.26 ± 0.27 c/min, respectively. ETOH (8 mL/L) resulted in complete relaxation of the SO within 10 s (Figure 2 I-L). After this time neither frequencies nor amplitudes could be detected during the remaining part of the experiments.

DISCUSSION

It has been widely known for a long time that ETOH may evoke acute pancreatitis[23]. The role of SO in the pathogenesis of alcohol-induced acute pancreatitis has also been suggested[3,6]. However, the effect of ETOH on SO is controversial. On the one hand, it has been demonstrated that ETOH reduces the SO pressure[3,6]. On the other hand, alcohol was found to induce spasm of the SO[24,25]. These contradictory results indicate that much more information is needed to clarify the effect of ETOH on SO motility.

To investigate these issues, we tested the effect of four different concentrations of ETOH on the resting SO motility. ETOH (2 mL/L) had no effect on the basal SO motility. This result is in accordance with the findings of Cullen et al[26]. They reported that ETOH at a dose of 2 mL/L had no significant effect on the baseline amplitude and the contractile frequency of SO in opossum. ETOH (4 mL/L) mildly decreased the baseline amplitude of the spontaneously contracting SO, but had no effect on the contractile frequency. When ETOH concentration was elevated to 6 mL/L, both the baseline SO contractile amplitude and the frequency were decreased (13%, 34% respectively), while 8 mL/L of ETOH completely relaxed the SO.

Next we tested the effect of different doses of ETOH on physiologically stimulated SO motility (carbachol, erythromycin and CCK). We tested 3 different stimuli at the ED50 doses. Carbachol was used to mimic the activity of parasympathetic nervous system, while CCK and a motilin receptor agonist erythromycin were administered to mimic neurohumoral stimuli.

Carbachol (0.1 μmol/L) stimulated the frequency (150%) and the amplitude (82%) of SO contractions. ETOH (2 mL/L) decreased the baseline amplitude and frequency of the carbachol-stimulated SO by the same rate (12%). ETOH (4 mL/L) decreased the amplitude of SO motility to the basal level, but the frequency still remained elevated. A 4-5 min administration of 6 mL/L ETOH completely relaxed the SO. These results demonstrate that ETOH may inhibit the activity of SO motility stimulated by the parasympathetic nervous system in a dose-dependent manner. Moreover, we can conclude that ETOH has a stronger effect on the contractile amplitude than on the frequency of SO.

The effect of ETOH was almost the same on erythromycin-stimulated as on carbachol-stimulated SO. ETOH (2 mL/L) mildly decreased the baseline amplitude and frequency by 10%. ETOH (4 mL/L) decreased both the amplitude and the frequency of erythromycin-stimulated SO. A 4-5 min administration of 6 mL/L ETOH completely relaxed the SO, as it was found during carbachol-stimulation.

Finally, the effect of ETOH was tested on CCK-stimulated SO motility. CCK stimulated the baseline amplitude and the contractile frequency of SO by 39 % and 74%, respectively. ETOH (2 mL/L) mildly decreased the baseline amplitude (6 mL/L), but had no effect on the frequency of the SO. ETOH (4 mL/L) further decreased the baseline amplitude. Interestingly, 4 mL/L ETOH still had no effect on the contractile frequency. When the concentration of ETOH was increased to 6 mL/L, both the baseline amplitude and the contractile frequency of SO were decreased (29% and 23% respectively). ETOH (8 mL/L) immediately and completely relaxed the SO as it was seen during the study of unstimulated SO.

Taken together, ETOH inhibited the basal and neurally (carbachol), hurmorally (erythromycin, a motilin agonist) and neurohumorally (CCK) stimulated SO motility in a dose-dependent manner. Viceconte et al[6] suggested that alcohol might cause a hormone-mediated relaxation, but they could not exclude a nervous or direct mechanism. Cullen et al[26] demonstrated that 2 mL/L ETOH could decrease the frequency of H2O2 -stimulated SO motility. These findings suggest that the main effect of alcohol is direct, independent of a specific neural and/or humoral pathway. Interestingly, we have to note that the inhibitory effect of ETOH was more pronounced during carbachol or erythromycin stimulation than during CCK stimulation. Therefore, we could not totally exclude a marginal specific effect of ETOH. There is no data available concerning the effect of low doses of ETOH on the SO in human. However, gastric absorption accounted for 30% of ETOH administered with food[27], therefore, during a low alcohol-concentrated-fluid (2%-5%) intake, small doses of alcohol may be found around the SO. These findings need further investigation.

The inhibitory effect of ETOH on SO motility may have an important pathophysiological role. ETOH has been found to increase basal pancreatic flow rate and protein output[28,29], thus, elevating the intraluminal pressure in the pancreatic ductal system. The relaxation of SO opens the way for pancreatic fluid to flow out into the duodenum, thus, preventing the pancreas from the damage by the elevated intraluminal pressure during acute ETOH administration. It is hard to believe, that a duodeno-pancreatic reflux against the high pancreatic-juice-flow could play a decisive role in the pathogenesis of alcohol-induced acute pancreatitis. Furthermore, it is also well documented that SO relaxants[30-32] and endoscopic sphincterotomy[33,34] have benefical effects during acute pancreatitis, which argue against the duodeno-pancreatic reflux theory. All in all, we think that the response of SO motility to ETOH administration is protective against pancreatic injury rather than harmful to the pancreas.

In conclusion, ETOH can strongly inhibit the basal, carbachol, erythromycin, and CCK stimulated SO motility in rabbits, and it is possible that SO opens the way for the pancreatic fluid to flow out into the duodenum. This relaxation of the SO may prevent the pancreas against alcohol-induced damage.

Footnotes

Edited by Wang XL Proofread by Zhu LH and Xu FM

References
1.  Schneider A, Whitcomb DC, Singer MV. Animal models in alcoholic pancreatitis--what can we learn? Pancreatology. 2002;2:189-203.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Dubagunta S, Still CD, Komar MJ. Acute pancreatitis. J Am Osteopath Assoc. 2001;101:S6-S9.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Yamasaki K, Okazaki K, Sakamoto Y, Yamamoto Y, Yamamoto Y, Okada T. Effects of ethanol on the motility of papillary sphincter and exocrine pancreas in the monkey. Am J Gastroenterol. 1993;88:2078-2083.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Becker JM, Sharp SW. Effect of alcohol on cyclical myoelectric activity of the opossum sphincter of Oddi. J Surg Res. 1985;38:343-349.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Goff JS. The effect of ethanol on the pancreatic duct sphincter of Oddi. Am J Gastroenterol. 1993;88:656-660.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Viceconte G. Effects of ethanol on the sphincter of Oddi: an endoscopic manometric study. Gut. 1983;24:20-27.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Harada T, Katsuragi T, Furukawa T. Release of acetylcholine mediated by cholecystokinin receptor from the guinea pig sphincter of Oddi. J Pharmacol Exp Ther. 1986;239:554-558.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Becker JM, Moody FG. The dose/response effects of gastrointestinal hormones on the opossum biliary sphincter. Curr Surg. 1980;37:60-62.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Sarles JC, Delecourt P, Castello H, Gaeta L, Nacchiero M, Amoros JP, Devaux MA, Awad R. Action of gastrointestinal hormones on the myoelectric activity of the sphincter of Oddi in living rabbit. Regul Pept. 1981;2:113-124.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Chiu JH, Kuo YL, Lui WY, Wu CW, Hong CY. Somatic electrical nerve stimulation regulates the motility of sphincter of Oddi in rabbits and cats: evidence for a somatovisceral reflex mediated by cholecystokinin. Dig Dis Sci. 1999;44:1759-1767.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Elbrønd H, Ostergaard L, Huniche B, Larsen LS, Andersen MB. Rabbit sphincter of Oddi and duodenal pressure and slow-wave activity. Effects of cholecystokinin. Scand J Gastroenterol. 1994;29:537-544.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Muller EL, Lewinski MA, Pitt HA. Action of cholecystokinin on sphincter of Oddi phasic wave activity in the prairie dog. Curr Surg. 1985;42:128-130.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Vergara P, Woskowska Z, Cipris S, Fox-Threlkeld JE, Daniel EE. Mechanisms of action of cholecystokinin in the canine gastrointestinal tract: role of vasoactive intestinal peptide and nitric oxide. J Pharmacol Exp Ther. 1996;279:306-316.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Pozo MJ, Salido GM, Madrid JA. Action of cholecystokinin on the dog sphincter of Oddi: influence of anti-cholinergic agents. Arch Int Physiol Biochim. 1990;98:353-360.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Chaussade S, Michopoulos S, Sogni P, Guerre J, Couturier D. Motilin agonist erythromycin increases human lower esophageal sphincter pressure by stimulation of cholinergic nerves. Dig Dis Sci. 1994;39:381-384.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Bormans V, Peeters TL, Janssens J, Pearce D, Vandeweerd M, Vantrappen G. In man, only activity fronts that originate in the stomach correlate with motilin peaks. Scand J Gastroenterol. 1987;22:781-784.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Sarles JC, Delecourt P, Devaux MA, Amoros JP, Guicheney JC, Wünsch E. In vivo effect of 13 Leu motilin on the electric activity of the rabbit sphincter of Oddi. Horm Metab Res. 1981;13:340-342.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Kaufman HS, Ahrendt SA, Pitt HA, Lillemoe KD. The effect of erythromycin on motility of the duodenum, sphincter of Oddi, and gallbladder in the prairie dog. Surgery. 1993;114:543-548.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Saccone GT, Liu YF, Thune A, Harvey JR, Baker RA, Toouli J. Erythromycin and motilin stimulate sphincter of Oddi motility and inhibit trans-sphincteric flow in the Australian possum. Naunyn Schmiedebergs Arch Pharmacol. 1992;346:701-706.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Wehrmann T, Pfeltzer C, Caspary WF. Effect of erythromycin on human biliary motility. Aliment Pharmacol Ther. 1996;10:421-426.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Konomi H, Simula ME, Meedeniya AC, Toouli J, Saccone GT. Induction of duodenal motility activates the sphincter of Oddi (SO)-duodenal reflex in the Australian possum in vitro. Auton Autacoid Pharmacol. 2002;22:109-117.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Lonovics J, Jakab I, Szilvássy J, Szilvássy Z. Regional differences in nitric oxide-mediated relaxation of the rabbit sphincter of Oddi. Eur J Pharmacol. 1994;255:117-122.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Sarles H, Lebreuil G, Tasso F, Figarella C, Clemente F, Devaux MA, Fagonde B, Payan H. A comparison of alcoholic pancreatitis in rat and man. Gut. 1971;12:377-388.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Sarles JC, Midejean A, Devaux MA. Electromyography of the sphincter of Oddi. Technic and experimental results in the rabbit: Effect of certain drugs. Am J Gastroenterol. 1975;63:221-231.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Guelrud M, Mendoza S, Rossiter G, Gelrud D, Rossiter A, Souney PF. Effect of local instillation of alcohol on sphincter of Oddi motor activity: combined ERCP and manometry study. Gastrointest Endosc. 1991;37:428-432.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Cullen JJ, Ledlow A, Murray JA, Conklin JL. Effect of hydroxyl radical (OH.) on sphincter of Oddi motility. Digestion. 1997;58:452-457.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Levitt MD, Li R, DeMaster EG, Elson M, Furne J, Levitt DG. Use of measurements of ethanol absorption from stomach and intestine to assess human ethanol metabolism. Am J Physiol. 1997;273:G951-G957.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Alonso RM, Alvarez MC, San Román JI, García LJ, Calvo JJ, López MA. Effects of acute intravenous ethanol on basal exocrine pancreatic secretion in rat: cholinergic involvement. Rev Esp Fisiol. 1994;50:81-87.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  Nakamura T, Okabayashi Y, Fujii M, Tani S, Fujisawa T, Otsuki M. Effect of ethanol on pancreatic exocrine secretion in rats. Pancreas. 1991;6:571-577.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Lai KH. Sphincter of Oddi and acute pancreatitis: a new treatment option. JOP. 2002;3:83-85.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  Lai KH, Lo GH, Cheng JS, Fu MT, Wang EM, Chan HH, Wang YY, Hsu PI, Lin CK. Effect of somatostatin on the sphincter of Oddi in patients with acute non-biliary pancreatitis. Gut. 2001;49:843-846.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Velõsy B, Madácsy L, Szepes A, Pávics L, Csernay L, Lonovics J. The effects of somatostatin and octreotide on the human sphincter of Oddi. Eur J Gastroenterol Hepatol. 1999;11:897-901.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Zhou MQ, Li NP, Lu RD. Duodenoscopy in treatment of acute gallstone pancreatitis. Hepatobiliary Pancreat Dis Int. 2002;1:608-610.  [PubMed]  [DOI]  [Cited in This Article: ]
34.  Park SH, Watkins JL, Fogel EL, Sherman S, Lazzell L, Bucksot L, Lehman GA. Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram. Gastrointest Endosc. 2003;57:483-491.  [PubMed]  [DOI]  [Cited in This Article: ]